Dec. 23, 2021 -- The antiviral remdesivir, an intravenous drug given generally to very seriously sick COVID-19 clients in hospitals,...
Remdesivir
TUESDAY, June two, 2020 (HealthDay Information) -- The California-centered pharmaceutical firm Gilead announced that its experimental antiviral drug remdesivir improved...
